RPCI Cancer Talk

Christy Paddon, a medical social worker at Roswell Park, with a patient.
So Why Do Many People Avoid It?
Tuesday, February 28, 2017 - 9:46am

Cancer patients often experience pain, nausea, emotional distress, and other symptoms caused by the disease and/or the side effects of treatment. Their caregivers may become stressed and overwhelmed, too. When those issues grow beyond basic, expected side effects and are no longer under control, supportive and palliative care can help.

Monday, February 27, 2017 - 3:01pm

Lymphoma is a cancer that starts in the infection-fighting cells of the immune system, called lymphocytes. These cells are in the lymph nodes, spleen, thymus, bone marrow, and other parts of the body. There are many types of lymphoma, and the risk factors vary.

Having one or more risk factors does not mean that you will develop lymphoma. Most people who have an increased risk never develop the disease. However, It's important to know your family and medical history and recognize any genetic factors.  

Hodgkin lymphoma risk factors:

Saturday, February 25, 2017 - 9:00am

If you have coronary artery disease, congestive heart failure, atrial fibrillation or any other heart condition, what does this mean for you if you have cancer? It means you should seek a consultation with a cardio-oncologist.

Friday, February 24, 2017 - 10:41am

You may not realize it, but your body is home to a lot of microbes — way more than you might think. In healthy humans, “microbial cells outnumber human cells by about ten to one,” according to the Human Microbiome Project of the National Institutes of Health. Most of them, called gut flora, live in your digestive system, especially in the colon. Others live in distinct communities in and on your body,  in different types of environments — hot or cold, moist or dry.

Thursday, February 23, 2017 - 5:00pm
Director of the Blood and Marrow Transplant Center at Roswell Park, Philip McCarthy, MD.

The U.S. Food and Drug Administration approved a new indication for the oral drug lenalidomide (brand name Revlimid) as a maintenance therapy for multiple myeloma patients following autologous hematopoietic stem cell transplant (ASCT), also known as autologous blood and marrow transplant (BMT).

Wednesday, February 22, 2017 - 2:38pm

Thyroid nodules are common and found in 10 percent of the adult population. Luckily, 95 percent of them are benign. When a thyroid nodule is suspicious - meaning that it has characteristics that suggest thyroid cancer - the next step is usually a fine needle aspiration biopsy (FNAB).

Monday, February 20, 2017 - 10:57am

If your treatment plan includes surgery, the recovery process may seem overwhelming. You may be on a restricted diet or experience limited movement and pain after a major operation. Enhanced Recovery After Surgery (ERAS) is a program that allows for a smoother, faster recovery by changing the way you prepare for surgery and your post-op care.

Saturday, February 18, 2017 - 10:26am

The National Cancer Institute (NCI) established an initiative recently that I expect to benefit patients at Roswell Park Cancer Institute (RPCI) and around the country for years to come.

In January 2017, the agency, a member institution of the National Institutes of Health, launched the NCI Formulary to expand access to both approved drugs and investigational agents — that is, drugs still in development — that have shown promise as possible cancer therapies.

Friday, February 17, 2017 - 3:32pm

During my post-doctoral fellowship at Roswell Park, I found my true calling – to help students discover their passion for science.

Thursday, February 16, 2017 - 2:31pm
Gal Shafirstein, DSc, Director of PDT Clinical Research (left), and PDT Nurse Michele Cooper, RN, BSN (right), show George Grace the type of laser that was used for his treatment with photodynamic therapy.

Take it from George Grace: if you’ve smoked your entire life, you listen closely to news about innovative cancer treatments. Grace listened, even before a spot on his lung led to a diagnosis of early-stage non-small cell lung cancer.